Skip to content
Institutional Investor early-stage mid-stage Est. 2002

SCP Vitalife

VC firm investing in early and mid-stage companies primarily in Israel and the US

📍 Malvern, United States

About This Fund

SCP Vitalife is a venture capital firm investing in early and mid-stage companies primarily in Israel and the US. Investment areas include Life Science, HealthTech, FinTech, etc. Some of the notable portfolio companies are Avedro, Ivenix, BioControl Medical, MediGuide, etc.

Investment Focus

Sectors
life sciences medical devices biopharma
Stages
early-stage mid-stage
Check Size $3M-$7M initial, $7M-$15M total
Geography
USA Israel

What They Look For

exceptional technology or proprietary advantages; poised to capitalize on major market trends; strong IP; >50% allocation to Israeli companies or significant R&D/ops ties to Israel, remainder US-based

Preparing to pitch SCP Vitalife?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →